Neurocrine Bioscienc (NBIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NBIX | UTHR | SMMT | ||
| Company | Neurocrine Bioscienc | United Therapeutic | Summit Therapeu ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 156.71 | 563.04 | 17.87 | ||
| High | 159.08 | 563.04 | 18.50 | ||
| Low | 155.43 | 548.03 | 17.36 | ||
| Latest | 158.30 | 556.82 | 17.54 | ||
| Change | +1.91 | -5.27 | +0.13 | ||
| % Change | +1.22% | -0.94% | +0.75% | ||
| Volume | 1,907,800 | 657,400 | 7,214,000 | ||
| 20-Day Average Volume | 1,288,865 | 478,005 | 4,693,980 | ||
| Previous Close | 156.39 | 562.09 | 17.41 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 151.98 | 571.52 | 17.41 | ||
| 20-Day Raw Stochastic | 87.43% | 14.33% | 56.14% | ||
| 20-Day Relative Strength | 67.85 | 47.02 | 47.22 | ||
| Weighted Alpha | +30.69 | +58.53 | +1.31 | ||
| Today's Opinion | 56% Buy | 56% Buy | 24% Sell | ||
| Previous Opinion | 56% Buy | 64% Buy | 40% Sell | ||
| Last Month's Opinion | 56% Sell | 88% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.80% since 05/21/26 | -1.60% since 05/21/26 | +0.40% since 05/21/26 | ||
| Low | 154.32 on 05/28/26 | 548.03 on 05/29/26 | 15.89 on 05/26/26 | ||
| High | 159.08 on 05/29/26 | 580.39 on 05/27/26 | 18.50 on 05/29/26 | ||
| 1-Month | |||||
| %Chg | +20.63% since 04/29/26 | -2.50% since 04/29/26 | -15.79% since 04/29/26 | ||
| Low | 129.76 on 04/30/26 | 548.03 on 05/29/26 | 15.14 on 05/01/26 | ||
| High | 162.39 on 05/14/26 | 609.35 on 05/06/26 | 22.38 on 04/30/26 | ||
| 3-Month | |||||
| %Chg | +19.70% since 02/27/26 | +10.50% since 02/27/26 | +5.73% since 02/27/26 | ||
| Low | 125.11 on 03/24/26 | 471.29 on 03/06/26 | 14.60 on 03/06/26 | ||
| High | 162.39 on 05/14/26 | 609.35 on 05/06/26 | 29.23 on 04/21/26 | ||
| 6-Month | |||||
| %Chg | +4.04% since 11/28/25 | +14.57% since 11/28/25 | -1.96% since 11/28/25 | ||
| Low | 122.14 on 02/12/26 | 455.63 on 01/20/26 | 13.83 on 02/05/26 | ||
| High | 162.39 on 05/14/26 | 609.35 on 05/06/26 | 29.23 on 04/21/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 15,917,066 | 23,635,336 | 13,613,900 | ||
| Shares Outstanding, K | 100,550 | 42,447 | 776,163 | ||
| Annual Sales | 2,860,500,000 | 3,182,700,000 | 0 | ||
| Annual Net Income | 478,600,000 | 1,334,700,000 | -1,079,590,000 | ||
| Last Quarter Sales | 814,500,000 | 781,500,000 | 0 | ||
| Last Quarter Net Income | 197,900,000 | 274,900,000 | -189,420,000 | ||
| 60-Month Beta | 0.34 | 0.60 | -1.25 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.94 on 05/05/26 | 5.82 on 05/06/26 | -0.24 on 04/30/26 | ||
| Earnings Date | 07/29/26 | 07/29/26 | 08/10/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 26.33 | 20.75 | 0.00 | ||